Takeda Pharmaceutical Co Ltd (TAK) — 6-K Filings
All 6-K filings from Takeda Pharmaceutical Co Ltd. Browse 3 Foreign Current Report reports with AI-powered summaries and risk analysis.
6-K Filings (3)
-
Takeda Pharmaceutical Files 6-K Report
— Mar 30, 2026 Risk: low
Takeda Pharmaceutical Co Ltd filed a 6-K report on March 30, 2026. The filing includes various documents, such as the 6-K form itself and supplementary exhibits -
Takeda Files Routine 6-K Foreign Issuer Report
— Mar 26, 2026
Takeda Pharmaceutical Co Ltd filed a 6-K report on March 26, 2026, indicating a routine foreign issuer report. This filing, with accession number 0001395064-26- -
Takeda Files Routine 6-K Report; No New Material Info
— Mar 25, 2026
Takeda Pharmaceutical Co Ltd filed a routine 6-K report on March 25, 2026, indicating no new material financial or operational information beyond standard repor
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX